Rett Syndrome Market - Global Outlook and Forecast 2022-2028

February 2022 | 61 pages | ID: R28833113C63EN
Market Monitor Global

Abstracts

Rett syndrome (RTT) is a genetic brain disorder which typically becomes apparent after 6 to 18 months of age in females. Symptoms include problems with language, coordination, and repetitive movements. Often there is slower growth, problems walking, and a smaller head size.

This report contains market size and forecasts of Rett Syndrome in Global, including the following market information:

Global Rett Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Rett Syndrome market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

BHV-5000 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Rett Syndrome include Anavex Life Sciences Corp., Neuren Pharmaceuticals Limited, Neuroloxis, Newron Pharmaceuticals, GW Pharmaceuticals Plc, Eloxx Pharmaceuticals Ltd, AveXis Inc, Amorsa Therapeutics Inc and AMO Pharma Ltd. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rett Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Rett Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Rett Syndrome Market Segment Percentages, by Type, 2021 (%)

• BHV-5000
• Bryostatin-1
• CPT-157633
• ELX-02
• Others

Global Rett Syndrome Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Rett Syndrome Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Rett Syndrome Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Rett Syndrome Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Rett Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Rett Syndrome revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Anavex Life Sciences Corp.
• Neuren Pharmaceuticals Limited
• Neuroloxis
• Newron Pharmaceuticals
• GW Pharmaceuticals Plc
• Eloxx Pharmaceuticals Ltd
• AveXis Inc
• Amorsa Therapeutics Inc
• AMO Pharma Ltd

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Rett Syndrome Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Rett Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RETT SYNDROME OVERALL MARKET SIZE

2.1 Global Rett Syndrome Market Size: 2021 VS 2028
2.2 Global Rett Syndrome Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Rett Syndrome Players in Global Market
3.2 Top Global Rett Syndrome Companies Ranked by Revenue
3.3 Global Rett Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Rett Syndrome Companies in Global Market, by Revenue in 2021
3.5 Global Companies Rett Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rett Syndrome Players in Global Market
  3.6.1 List of Global Tier 1 Rett Syndrome Companies
  3.6.2 List of Global Tier 2 and Tier 3 Rett Syndrome Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Rett Syndrome Market Size Markets, 2021 & 2028
  4.1.2 BHV-5000
  4.1.3 Bryostatin-1
  4.1.4 CPT-157633
  4.1.5 ELX-02
  4.1.6 Others
4.2 By Type - Global Rett Syndrome Revenue & Forecasts
  4.2.1 By Type - Global Rett Syndrome Revenue, 2017-2022
  4.2.2 By Type - Global Rett Syndrome Revenue, 2023-2028
  4.2.3 By Type - Global Rett Syndrome Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Rett Syndrome Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Rett Syndrome Revenue & Forecasts
  5.2.1 By Application - Global Rett Syndrome Revenue, 2017-2022
  5.2.2 By Application - Global Rett Syndrome Revenue, 2023-2028
  5.2.3 By Application - Global Rett Syndrome Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Rett Syndrome Market Size, 2021 & 2028
6.2 By Region - Global Rett Syndrome Revenue & Forecasts
  6.2.1 By Region - Global Rett Syndrome Revenue, 2017-2022
  6.2.2 By Region - Global Rett Syndrome Revenue, 2023-2028
  6.2.3 By Region - Global Rett Syndrome Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Rett Syndrome Revenue, 2017-2028
  6.3.2 US Rett Syndrome Market Size, 2017-2028
  6.3.3 Canada Rett Syndrome Market Size, 2017-2028
  6.3.4 Mexico Rett Syndrome Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Rett Syndrome Revenue, 2017-2028
  6.4.2 Germany Rett Syndrome Market Size, 2017-2028
  6.4.3 France Rett Syndrome Market Size, 2017-2028
  6.4.4 U.K. Rett Syndrome Market Size, 2017-2028
  6.4.5 Italy Rett Syndrome Market Size, 2017-2028
  6.4.6 Russia Rett Syndrome Market Size, 2017-2028
  6.4.7 Nordic Countries Rett Syndrome Market Size, 2017-2028
  6.4.8 Benelux Rett Syndrome Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Rett Syndrome Revenue, 2017-2028
  6.5.2 China Rett Syndrome Market Size, 2017-2028
  6.5.3 Japan Rett Syndrome Market Size, 2017-2028
  6.5.4 South Korea Rett Syndrome Market Size, 2017-2028
  6.5.5 Southeast Asia Rett Syndrome Market Size, 2017-2028
  6.5.6 India Rett Syndrome Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Rett Syndrome Revenue, 2017-2028
  6.6.2 Brazil Rett Syndrome Market Size, 2017-2028
  6.6.3 Argentina Rett Syndrome Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Rett Syndrome Revenue, 2017-2028
  6.7.2 Turkey Rett Syndrome Market Size, 2017-2028
  6.7.3 Israel Rett Syndrome Market Size, 2017-2028
  6.7.4 Saudi Arabia Rett Syndrome Market Size, 2017-2028
  6.7.5 UAE Rett Syndrome Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Anavex Life Sciences Corp.
  7.1.1 Anavex Life Sciences Corp. Corporate Summary
  7.1.2 Anavex Life Sciences Corp. Business Overview
  7.1.3 Anavex Life Sciences Corp. Rett Syndrome Major Product Offerings
  7.1.4 Anavex Life Sciences Corp. Rett Syndrome Revenue in Global Market (2017-2022)
  7.1.5 Anavex Life Sciences Corp. Key News
7.2 Neuren Pharmaceuticals Limited
  7.2.1 Neuren Pharmaceuticals Limited Corporate Summary
  7.2.2 Neuren Pharmaceuticals Limited Business Overview
  7.2.3 Neuren Pharmaceuticals Limited Rett Syndrome Major Product Offerings
  7.2.4 Neuren Pharmaceuticals Limited Rett Syndrome Revenue in Global Market (2017-2022)
  7.2.5 Neuren Pharmaceuticals Limited Key News
7.3 Neuroloxis
  7.3.1 Neuroloxis Corporate Summary
  7.3.2 Neuroloxis Business Overview
  7.3.3 Neuroloxis Rett Syndrome Major Product Offerings
  7.3.4 Neuroloxis Rett Syndrome Revenue in Global Market (2017-2022)
  7.3.5 Neuroloxis Key News
7.4 Newron Pharmaceuticals
  7.4.1 Newron Pharmaceuticals Corporate Summary
  7.4.2 Newron Pharmaceuticals Business Overview
  7.4.3 Newron Pharmaceuticals Rett Syndrome Major Product Offerings
  7.4.4 Newron Pharmaceuticals Rett Syndrome Revenue in Global Market (2017-2022)
  7.4.5 Newron Pharmaceuticals Key News
7.5 GW Pharmaceuticals Plc
  7.5.1 GW Pharmaceuticals Plc Corporate Summary
  7.5.2 GW Pharmaceuticals Plc Business Overview
  7.5.3 GW Pharmaceuticals Plc Rett Syndrome Major Product Offerings
  7.5.4 GW Pharmaceuticals Plc Rett Syndrome Revenue in Global Market (2017-2022)
  7.5.5 GW Pharmaceuticals Plc Key News
7.6 Eloxx Pharmaceuticals Ltd
  7.6.1 Eloxx Pharmaceuticals Ltd Corporate Summary
  7.6.2 Eloxx Pharmaceuticals Ltd Business Overview
  7.6.3 Eloxx Pharmaceuticals Ltd Rett Syndrome Major Product Offerings
  7.6.4 Eloxx Pharmaceuticals Ltd Rett Syndrome Revenue in Global Market (2017-2022)
  7.6.5 Eloxx Pharmaceuticals Ltd Key News
7.7 AveXis Inc
  7.7.1 AveXis Inc Corporate Summary
  7.7.2 AveXis Inc Business Overview
  7.7.3 AveXis Inc Rett Syndrome Major Product Offerings
  7.7.4 AveXis Inc Rett Syndrome Revenue in Global Market (2017-2022)
  7.7.5 AveXis Inc Key News
7.8 Amorsa Therapeutics Inc
  7.8.1 Amorsa Therapeutics Inc Corporate Summary
  7.8.2 Amorsa Therapeutics Inc Business Overview
  7.8.3 Amorsa Therapeutics Inc Rett Syndrome Major Product Offerings
  7.8.4 Amorsa Therapeutics Inc Rett Syndrome Revenue in Global Market (2017-2022)
  7.8.5 Amorsa Therapeutics Inc Key News
7.9 AMO Pharma Ltd
  7.9.1 AMO Pharma Ltd Corporate Summary
  7.9.2 AMO Pharma Ltd Business Overview
  7.9.3 AMO Pharma Ltd Rett Syndrome Major Product Offerings
  7.9.4 AMO Pharma Ltd Rett Syndrome Revenue in Global Market (2017-2022)
  7.9.5 AMO Pharma Ltd Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Rett Syndrome Market Opportunities & Trends in Global Market
Table 2. Rett Syndrome Market Drivers in Global Market
Table 3. Rett Syndrome Market Restraints in Global Market
Table 4. Key Players of Rett Syndrome in Global Market
Table 5. Top Rett Syndrome Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Rett Syndrome Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Rett Syndrome Revenue Share by Companies, 2017-2022
Table 8. Global Companies Rett Syndrome Product Type
Table 9. List of Global Tier 1 Rett Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rett Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Rett Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Rett Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Rett Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Rett Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Rett Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Rett Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Rett Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Rett Syndrome Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Rett Syndrome Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Rett Syndrome Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Rett Syndrome Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Rett Syndrome Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Rett Syndrome Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Rett Syndrome Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Rett Syndrome Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Rett Syndrome Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Rett Syndrome Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Rett Syndrome Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Rett Syndrome Revenue, (US$, Mn), 2023-2028
Table 30. Anavex Life Sciences Corp. Corporate Summary
Table 31. Anavex Life Sciences Corp. Rett Syndrome Product Offerings
Table 32. Anavex Life Sciences Corp. Rett Syndrome Revenue (US$, Mn), (2017-2022)
Table 33. Neuren Pharmaceuticals Limited Corporate Summary
Table 34. Neuren Pharmaceuticals Limited Rett Syndrome Product Offerings
Table 35. Neuren Pharmaceuticals Limited Rett Syndrome Revenue (US$, Mn), (2017-2022)
Table 36. Neuroloxis Corporate Summary
Table 37. Neuroloxis Rett Syndrome Product Offerings
Table 38. Neuroloxis Rett Syndrome Revenue (US$, Mn), (2017-2022)
Table 39. Newron Pharmaceuticals Corporate Summary
Table 40. Newron Pharmaceuticals Rett Syndrome Product Offerings
Table 41. Newron Pharmaceuticals Rett Syndrome Revenue (US$, Mn), (2017-2022)
Table 42. GW Pharmaceuticals Plc Corporate Summary
Table 43. GW Pharmaceuticals Plc Rett Syndrome Product Offerings
Table 44. GW Pharmaceuticals Plc Rett Syndrome Revenue (US$, Mn), (2017-2022)
Table 45. Eloxx Pharmaceuticals Ltd Corporate Summary
Table 46. Eloxx Pharmaceuticals Ltd Rett Syndrome Product Offerings
Table 47. Eloxx Pharmaceuticals Ltd Rett Syndrome Revenue (US$, Mn), (2017-2022)
Table 48. AveXis Inc Corporate Summary
Table 49. AveXis Inc Rett Syndrome Product Offerings
Table 50. AveXis Inc Rett Syndrome Revenue (US$, Mn), (2017-2022)
Table 51. Amorsa Therapeutics Inc Corporate Summary
Table 52. Amorsa Therapeutics Inc Rett Syndrome Product Offerings
Table 53. Amorsa Therapeutics Inc Rett Syndrome Revenue (US$, Mn), (2017-2022)
Table 54. AMO Pharma Ltd Corporate Summary
Table 55. AMO Pharma Ltd Rett Syndrome Product Offerings
Table 56. AMO Pharma Ltd Rett Syndrome Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Rett Syndrome Segment by Type in 2021
Figure 2. Rett Syndrome Segment by Application in 2021
Figure 3. Global Rett Syndrome Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Rett Syndrome Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rett Syndrome Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rett Syndrome Revenue in 2021
Figure 8. By Type - Global Rett Syndrome Revenue Market Share, 2017-2028
Figure 9. By Application - Global Rett Syndrome Revenue Market Share, 2017-2028
Figure 10. By Region - Global Rett Syndrome Revenue Market Share, 2017-2028
Figure 11. By Country - North America Rett Syndrome Revenue Market Share, 2017-2028
Figure 12. US Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Rett Syndrome Revenue Market Share, 2017-2028
Figure 16. Germany Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 17. France Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Rett Syndrome Revenue Market Share, 2017-2028
Figure 24. China Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 28. India Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Rett Syndrome Revenue Market Share, 2017-2028
Figure 30. Brazil Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Rett Syndrome Revenue Market Share, 2017-2028
Figure 33. Turkey Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Rett Syndrome Revenue, (US$, Mn), 2017-2028
Figure 37. Anavex Life Sciences Corp. Rett Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Neuren Pharmaceuticals Limited Rett Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Neuroloxis Rett Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Newron Pharmaceuticals Rett Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GW Pharmaceuticals Plc Rett Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Eloxx Pharmaceuticals Ltd Rett Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AveXis Inc Rett Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Amorsa Therapeutics Inc Rett Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. AMO Pharma Ltd Rett Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)